CPC Subgroup
C12Y 106/05 with a quinone or similar compound as acceptor (1.6.5)
Full Title
Oxidoreductases acting on NADH or NADPH (1.6) > with a quinone or similar compound as acceptor (1.6.5)
9 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 106/05002 NAD(P)H dehydrogenase (quinone) (1.6.5.2)
- C12Y 106/05003 NADH dehydrogenase (ubiquinone) (1.6.5.3)
- C12Y 106/05004 Monodehydroascorbate reductase (NADH) (1.6.5.4)
- C12Y 106/05005 NADPH:quinone reductase (1.6.5.5)
- C12Y 106/05006 p-Benzoquinone reductase (NADPH) (1.6.5.6)
- C12Y 106/05007 2-Hydroxy-1,4-benzoquinone reductase (1.6.5.7)
- C12Y 106/05008 NADH:ubiquinone reductase (Na+-transporting) (1.6.5.8)
- C12Y 106/05009 NADH:ubiquinone reductase (non-electrogenic) (1.6.5.9)
- C12Y 106/0501 NADPH dehydrogenase (quinone) (1.6.5.10)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692